Abbott today announced the first global procedures conducted with its new Volt pulsed field ablation system. Volt treats patients battling common abnormal heart rhythms like AFib. It marks Abbott’s entry into the crowded pulsed field ablation (PFA) space alongside companies like Medtronic, Boston Scientific and Johnson & Johnson’s Biosense Webster. Last month, Medtronic became the […]
Abbott
Diabetes unit continues to power growth at Abbott with Lingo coming to U.S. ‘soon’
With continued progress on established platforms, new acquisitions and new products, Abbott has high expectations for its Diabetes business. Speaking at the J.P. Morgan Healthcare Conference, CEO Robert Ford highlighted diabetes as a key area for near-term growth. Specifically, in the presentation transcribed by SeekingAlpha, Ford said he expects the FreeStyle Libre continuous glucose monitor […]
The biggest stories from the 2024 J.P. Morgan Healthcare Conference
Some of the biggest names in medtech came together this week at the J.P. Morgan Healthcare Conference. They shared updates on financial progress, operational changes and new products, among other things. Medtronic shared details on plans to restore earnings power, while Abbott highlighted the success of its FreeStyle Libre system. Shockwave Medical outlined its plans […]
Abbott integrates FreeStyle Libre 2 Plus into Tandem’s automated insulin pump
Abbott and Tandem Diabetes Care (Nasdaq:TNDM) today announced the integration of FreeStyle Libre 2 Plus CGM into the t:slim X2 insulin pump. This marks the first automated insulin delivery system to integrate the newly available Abbott FreeStyle Libre 2 Plus sensor. The FDA cleared the updated Abbott continuous glucose monitor (CGM) for use with automated insulin […]
The 10 biggest diabetes tech stories from 2023
It was another banner year for diabetes technology, with regulatory approvals, product launches and M&A all playing their part. Diabetes technology’s impressive 12 months marked a major trend across medtech as a whole, too. In 2022, the diabetes space saw plenty of progress from some of its biggest names and this past year proved no different. […]
The top medtech trends of 2023
The top medtech trends of 2023 included innovations such as artificial intelligence, new GLP-1 weight loss drugs and some long-awaited medtech finally receiving regulatory nods. With health providers facing additional challenges on top of an ever-uncertain economic environment, medtech companies also made major readjustments: layoffs, spinoffs, reorganizations and much more. Here are the top stories […]
‘A safe pair of hands’ — Medtech’s investment in Ireland continues to grow
Medtech established its presence in Ireland many years ago and still, companies continue to invest in the ever-growing country. Boston Scientific established operations in Ireland in 1994, while Abbott has more than 70 years in the country. Medtronic, now officially headquartered in Dublin, has spent more than 40 years in Ireland and even hosted its […]
Here’s what diabetes tech companies are doing on World Diabetes Day
Every November, the diabetes community comes together to recognize both National Diabetes Month in the U.S. and World Diabetes Day. World Diabetes Day falls on today, Nov. 14, to mark the birthday of Sir Frederick Banting. Banting discovered the insulin hormone along with Charles Herbert Best in 1922. In an effort to drive awareness and […]
Abbott launches dual-chamber pacemaker with first U.S. implants
The first U.S. commercial cases have been completed with the Abbott Aveir dual-chamber leadless pacemaker technology. Abbott announced in July that it received FDA approval for the Aveir system. The approval marked the first such nod for a dual-chamber leadless pacing system for treating abnormal or slow heart rhythms. According to Abbott, more than 80% […]
Abbott rolls out National Diabetes Awareness Month initiative to promote CGM use
Abbott (NYSE:ABT) announced today that it launched its new “Countdown at a Crossroads” initiative for National Diabetes Awareness Month. The initiative sees Abbott take over the Oculus Center in New York City with an animated installation promoting diabetes awareness. This installation features the faces and stories of people impacted by diabetes, including comedian and talk […]
Abbott teams up with NFL player Damar Hamlin for ‘HeartMates Program’
Abbott today announced a new initiative to help those impacted by heart conditions with Buffalo Bills safety Damar Hamlin. With this announcement, Hamlin becomes the first ambassador for the Abbott HeartMates Program. The program aims to create a community of support for people and caregivers impacted by heart conditions. It enables the sharing of stories […]